
Sign up to save your podcasts
Or
Dr. Iyad Alnahhas interviews Dr. Kathreena Kurian about her and her team's recent manuscript entitled: "MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Review", published online in Neuro-Oncology in April 2021.
4.8
1212 ratings
Dr. Iyad Alnahhas interviews Dr. Kathreena Kurian about her and her team's recent manuscript entitled: "MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Review", published online in Neuro-Oncology in April 2021.
38,723 Listeners
91,011 Listeners
293 Listeners
12,112 Listeners
2,327 Listeners
69,085 Listeners
165,748 Listeners
59,371 Listeners
317 Listeners
12,571 Listeners
28,527 Listeners
15,335 Listeners
8,892 Listeners
10,011 Listeners
7,762 Listeners